292 related articles for article (PubMed ID: 34374416)
21. Prognostic Implications of Novel Ten-Gene Signature in Uveal Melanoma.
Luo H; Ma C; Shao J; Cao J
Front Oncol; 2020; 10():567512. PubMed ID: 33194647
[No Abstract] [Full Text] [Related]
22. Identification of a novel immune-related gene signature for prognosis and the tumor microenvironment in patients with uveal melanoma combining single-cell and bulk sequencing data.
Wang W; Zhao H; Wang S
Front Immunol; 2023; 14():1099071. PubMed ID: 36793711
[TBL] [Abstract][Full Text] [Related]
23. Identification and validation of tumor microenvironment-related lncRNA prognostic signature for uveal melanoma.
Liao CL; Hu N; Sun XY; Zhou Q; Tian M; Cao Y; Lyu HB
Int J Ophthalmol; 2021; 14(8):1151-1159. PubMed ID: 34414077
[TBL] [Abstract][Full Text] [Related]
24. Identification of a prognostic six-immune-gene signature and a nomogram model for uveal melanoma.
Yang B; Fan Y; Liang R; Wu Y; Gu A
BMC Ophthalmol; 2023 Jan; 23(1):2. PubMed ID: 36597071
[TBL] [Abstract][Full Text] [Related]
25. Tumor subtypes and signature model construction based on chromatin regulators for better prediction of prognosis in uveal melanoma.
Li Y; Xiong C; Wu LL; Zhang BY; Wu S; Chen YF; Xu QH; Liao HF
Pathol Oncol Res; 2023; 29():1610980. PubMed ID: 37362244
[No Abstract] [Full Text] [Related]
26. Construction and verification of a hypoxia-related nine-gene prognostic model in uveal melanoma based on integrated single-cell and bulk RNA sequencing analyses.
Zhang X; Qiu J; Huang F; Han P; Shan K; Zhang C
Exp Eye Res; 2022 Oct; 223():109214. PubMed ID: 35981602
[TBL] [Abstract][Full Text] [Related]
27.
Meng Z; Chen Y; Wu W; Yan B; Zhang L; Chen H; Meng Y; Liang Y; Yao X; Luo J
Front Immunol; 2022; 13():754645. PubMed ID: 35281030
[TBL] [Abstract][Full Text] [Related]
28. Identification of prognostic genes in uveal melanoma microenvironment.
Luo H; Ma C
PLoS One; 2020; 15(11):e0242263. PubMed ID: 33196683
[TBL] [Abstract][Full Text] [Related]
29. Bioinformatic Analysis Reveals Central Role for Tumor-Infiltrating Immune Cells in Uveal Melanoma Progression.
Lachota M; Lennikov A; Malmberg KJ; Zagozdzon R
J Immunol Res; 2021; 2021():9920234. PubMed ID: 34195299
[TBL] [Abstract][Full Text] [Related]
30. Construction of immune-related risk signature for uveal melanoma.
Zhang Z; Ni Y; Chen G; Wei Y; Peng M; Zhang S
Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):912-919. PubMed ID: 32496920
[TBL] [Abstract][Full Text] [Related]
31. Integrative analyses of a mitophagy-related gene signature for predicting prognosis in patients with uveal melanoma.
Cheng Y; Liu J; Fan H; Liu K; Zou H; You Z
Front Genet; 2022; 13():1050341. PubMed ID: 36544483
[TBL] [Abstract][Full Text] [Related]
32. Development of a 3-MicroRNA Signature and Nomogram for Predicting the Survival of Patients with Uveal Melanoma Based on TCGA and GEO Databases.
Zuo J; Ye H; Tang J; Lu J; Wan Q
J Ophthalmol; 2022; 2022():9724160. PubMed ID: 36457950
[TBL] [Abstract][Full Text] [Related]
33. Alternative Splicing Events as Indicators for the Prognosis of Uveal Melanoma.
Wan Q; Sang X; Jin L; Wang Z
Genes (Basel); 2020 Feb; 11(2):. PubMed ID: 32098099
[TBL] [Abstract][Full Text] [Related]
34. Construction and Validation of a Novel Immunosignature for Overall Survival in Uveal Melanoma.
Gu C; Gu X; Wang Y; Yao Z; Zhou C
Front Cell Dev Biol; 2021; 9():710558. PubMed ID: 34552928
[TBL] [Abstract][Full Text] [Related]
35. Development and validation of an immune and stromal prognostic signature in uveal melanoma to guide clinical therapy.
Gong Q; Wan Q; Li A; Yu Y; Ding X; Lin L; Qi X; Hu L
Aging (Albany NY); 2020 Oct; 12(20):20254-20267. PubMed ID: 33100273
[TBL] [Abstract][Full Text] [Related]
36. Identification of co-expressed gene networks promoting CD8
Zhang C; Xiao J; Fa L; Jiang F; Jiang H; Zhou L; Xu Z
BMC Ophthalmol; 2023 Aug; 23(1):354. PubMed ID: 37563735
[TBL] [Abstract][Full Text] [Related]
37. Prognostic Value and Immunological Characteristics of a Novel RNA Binding Protein Signature in Cutaneous Melanoma.
Tian J; Ma C; Yang L; Sun Y; Zhang Y
Front Genet; 2021; 12():723796. PubMed ID: 34531901
[TBL] [Abstract][Full Text] [Related]
38. Identification of 5 microRNA biomarkers associated with the prognosis of uveal melanoma.
Sun Y; Zhang X; Cong Z; Teng S
Medicine (Baltimore); 2022 Sep; 101(35):e30366. PubMed ID: 36107591
[TBL] [Abstract][Full Text] [Related]
39. Construction and Verification of the Molecular Subtype and a Novel Prognostic Signature Based on Inflammatory Response-Related Genes in Uveal Melanoma.
Zhang F; Deng Y; Wang D; Wang S
J Clin Med; 2023 Jan; 12(3):. PubMed ID: 36769510
[TBL] [Abstract][Full Text] [Related]
40. Two Pyroptosis-Related Subtypes with Distinct Immune Microenvironment Characteristics and a Novel Signature for Predicting Immunotherapy Response and Prognosis in Uveal Melanoma.
Lei S; Li H
Curr Eye Res; 2022 Jun; 47(6):930-943. PubMed ID: 35348009
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
